It is common for those with celiac disease to turn to over-the-counter (OTC) or prescription loperamide (brand name: Imodium) for short-term treatment of diarrhea. The FDA has recently issued a warning that overuse of this medication can lead to serious cardiac issues, and even death. Users of loperamide are encouraged to adhere to recommended dosages […]
Patient Advocate Online Program
We fight to improve the lives of all people affected by celiac disease and non-celiac wheat sensitivity now
With more than 1,200 participants registered in its first four months, iCureCeliac™ is shaping the type of research that is most important to you – the patient. We are pleased to present a few initial findings.
It is a commonly held belief that, in America, celiac disease occurs most frequently in women of Caucasian descent. A recent study, led CDF Research Committee member Benjamin Lebwohl of the Celiac Disease Center at Columbia University, sought to examine that assertion, and turned up some unexpected information about the ethnic distribution of this widespread […]
Celiac Disease Foundation is proud to announce the establishment of the CDF Research Committee, chaired by Daniel Adelman, MD, with members Sonia Kupfer, MD, Benjamin Lebwohl, MD, and Fernando Velayos, MD. Committee members will select two representatives from CDF’s Patient Engagement Celiac Disease Network to join them in overseeing CDF’s research-related activities, including iCureCeliac™. Research […]
Boulder, Colorado, June 14, 2016 – Gluten-free pioneers and category leaders Glutino and Udi’s sponsored Celiac Awareness Month with a fundraising campaign benefitting the Celiac Disease Foundation to demonstrate their commitment to improving the lives of people who have celiac disease. During the month of May, Glutino and Udi’s raised $10,500 via the campaign for the Celiac Disease […]
For 25 years, Celiac Disease Foundation has helped families struggling with celiac disease. Watch this special message from father and daughter Board Members Marvin and Deidre Berman.